Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q2 2019 · 10-Q
Revenue$2.61M$2.61M+58.3% vs Q2 2018 Net Income-$1.55M-$1.55MN/M vs Q2 2018 EPS Diluted-$0.13-$0.13N/M vs Q2 2018 Operating Income-$1,293,068N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin-49.6%+49.8 pt vs Q2 2018
Net margin-59.5%+54.5 pt vs Q2 2018
ended Jun 30, 2019 · filed Aug 12, 2019 · 43 d after period end